Nanosignal: ist das einstieg Möglichkeit - 500 Beiträge pro Seite

[TecDax50]

Kann man mit diesen Kursen einsteigen.
Schon wieder tiefpunkt erreicht.

[microby]

Nein!

[Gluewuermchen]

Lass die Finger davon!

Der reinste Pushschei...!

[dusender]

@ Gluewuermchen

wir werden sehen !!!

[TecDax50]

Habt ihr auch ein argument dafür, warum dieser Firm ein Betrug ist.
Oder hängt das nur von kurs ab, weil der so niedrig ist.

[Andus]

Ob es sich bei Nanosignal um Betrug handelt, kann hier im Board wohl keiner beurteilen. Das wäre der Fall, wenn die nix mit Nanotechnologie zu tun hätten. Was aber kein Hindernis für einen Kursanstieg bedeuten muss, wie man bei anderen Möchtegern-Nanos sieht.

Wichtiger ist ob, ihre Software was taugt. Das kann ich ebenfalls nicht beurteilen. Ich weiß nur, das zu Zeit Tests laufen und wohl im März Ergebnisse vorliegen könnten. Ich weiß nicht ob negative Ergebnisse das Ende der Firma bedeuten.

In den letzten Tagen wurden für die Entwicklung der Firma scheinbar maßgebende Leute eingestellt. Es muss also doch etwas mehr Geld da sein, als zunächst von mir befürchtet. Die arbeiten wahrscheinlich kaum umsonst.

Aber schau mal auf die Charttechnik. Da ist in den letzten Wochen ein ganz netter Aufwärtstrend etabliert worden. Und im Langfristchart kleben wir an einem wichtigen Wiederstand. Sollte es durch die 0.25 gehen, könnte das Teil explodieren. Setz Dir halt einen Stopp an der 100-Tage-Linie. Könnte in diesem Fall aufgehen.

Bei 100% Plus sofort Einsatz raus!!!

[TecDax50]

wo guckt ihr den immer nach chart. Comdirect ist ja nicht so recht super.

Danke voraus. Ist ja vielleicht blöde frag aber vielleicht weiß ja jemand was besseres.

[Aeppler]

@tec

z.b. www.bigcharts.com

unter tech anal kannst du sortieren

so long

@eppler

[Andus]

Na bitte, scheinbar ein taugliches Produkt. Dürfte heut ein spannender Tag werden.


NanoSignal Corp. -- Formerly MicroSignal -- Reports Successful Beta Testing Results of SLICES, Sales & Marketing and Other Significant Developments
WEDNESDAY, FEBRUARY 11, 2004 11:47 PM
- BusinessWire


LAS VEGAS, Feb 11, 2004 (BUSINESS WIRE) -- NanoSignal Corp. (formerly Microsignal Corp.) (NNOS) reported today the highly successful and industry significant completion of the first phase of beta testing of SLICES(TM) software technology for MRI devices at Desert Radiology in Las Vegas, NV.

Dr. Lawrence Madoff, President of NanoSignal, reported that "the beta test results at Desert Radiology are historic not only for NanoSignal but for the MRI industry as a whole. With the help of Dr. Jeffrey Taft, Ph.D., who is the inventor and founder of SLICES(TM), we have been able to prove-up our technology in the field. We are no longer a start-up company, but a real contender for a share of the multi-million dollar MRI industry.

"Working with a standard 1.5 Tesla General Electric MRI scanner at Desert Radiology, we used SLICES(TM) to maintain signal noise and resolution in less than 50% of the usual scanning time while at the same time producing clear images suitable for radiological interpretation. This achievement is industry historic since it demonstrates that SLICES(TM) software not only works but works in half of the time. This means that patient pass through is increased resulting in medical cost savings and greater human comfort since time in the tunnel can be greatly shortened."

Our engineering team will continue beta testing at Desert Radiology over the next several weeks on both GE and other MRI devices manufactured by the leading companies in the business. Our objectives will be to increase resolution and improve image quality on all MRI devices, both tunnel configuration and the highly popular open MRI`s. Testing of SLICES(TM) integration with DICOM compatible PACS systems is progressing with a high degree of satisfaction. Significantly, our technical "White Paper" will include both the beta test results for SLICES(TM), a marketing plan, financial forecasts and statistical data for health insurers proving the cost benefits of SLICES(TM). We will be assisted by Ali Noshirvani, who has been selected to head-up sales and marketing, as previously announced in our Business Wire press release dated Feb. 5, 2004. We further anticipate ramping up a recruitment program for additional software engineers and installation technicians.

With beta testing near completion, our message to the MRI industry is that up-grading MRI devices with the new SLICES(TM) software versus the capital outlay for costlier MRI equipment is now a real choice. Given the size and depth of the MRI industry, we are open to multiple distribution channels such as direct sales, co-branding, sub-licensing and strategic alliances with MRI manufacturers. The best thing for our shareholders is to make SLICES(TM) the software of choice for all MRI manufacturers to replace the outdated image processing methodologies that is decades old. Everyone knows how successful "red eye" reduction has been to the camera and film industry. Now with SLICES(TM), MRI facilities have a one stop purchase to reduce artifacts and ghosting on images with increased productivity that pays for the software outlay.

The company has been in negotiations with multiple investment banking firms to meet its anticipated funding needs for national and international sales and marketing in 2004-2005. In order to concentrate on the beta testing and the medical applications of SLICES(TM), Dr. Madoff will continue as President of NanoSignal with the additional title of Chief Operating Officer. The Board of Directors and majority preferred shareholder have unanimously selected Scott Ervin to take on the responsibilities of Chief Executive Officer. Scott is a welcome member of the NanoSignal team and he will be instrumental in meeting the global demand for SLICES(TM).

Scott Erwin has enjoyed an impressive career in real estate management, finance, mergers-acquisitions and leasing with a number Fortune 500 caliber companies including the First Boston Corporation, Fisher Brothers, and Rockefeller Center, Inc. In November 2003, Mr. Erwin became President and CEO of Micro Bio-Medical Systems, Inc., a position which he will continue to hold indefinitely.

Additional information regarding SLICES(TM) and NanoSignal Corp. is available at www.nanosignalcorp.com.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management`s strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.

SOURCE: NanoSignal Corp.

[TecDax50]

#8
Danke für den Information.

Ich habe schon lange diese Aktie beobachtet.
Jetzt habe ich einstiegmöglichkeit verpasst.
Hatte heute ,17 order gegeben. Aber ist leider nicht ausgeführt.
Wünsche anderen viele Gewinne.
Vielleicht macht ja mal heute kleine rücksetzer bis ,17.

[TecDax50]

Habe auch diese Aktie mal in depo gelegt für ,17 euro.

Mal sehen was draus wird.

[Andus]

+13.54% bei eher schwachem Gesamtmarkt. Jetzt wirds drauf ankommen,ob es irgenwelche Kommentare zu dem Laden gibt. (Natürlich nicht hier im Board. Die meisten hier finden Nanosignal ja eh eher mist und werden sich vielleicht noch ärgern )

[Mondschein_xx]

Also ich habe Nano für ,168 € bekommen hoffe das was draus wird denn im Augenblick sind ja alle Nano-Aktien im freien Fall was meint Ihr??

wie wird es weitergehen?

[Andus]

NanoSignal Corp. CEO Comments on Current Developments and 2004 Outlook

WEDNESDAY, FEBRUARY 18, 2004 9:00 AM
- BusinessWire


LAS VEGAS, Feb 18, 2004 (BUSINESS WIRE) -- NanoSignal Corp.`s (OTC BB: NNOS) newly appointed chief executive Scott A. Ervin took the occasion to summarize the following recent developments, and to extend a message of greeting to the company`s shareholders and prospective investors.

First of all, the company`s common shares now trade on three foreign exchanges in addition to the OTC Bulletin Board. NanoSignal is trading as NNOS.F on the Frankfurt (Germany) Exchange and NNOS.BE on the Berlin (Germany) Exchange; also as NNOS.DE on the European Xetra Exchange.

"I am most pleased to be on board and heading up the NanoSignal Corp. team and organization," stated Ervin. "We are now positioned to take this company to the next level, and the near-term developments are extremely promising, providing NanoSignal the opportunity to attract a much more significant following within the Wall Street community. The company should be able to gain additional exposure and support, based on fundamentals and real progress of its business plan, as we move forward."

As previously referenced in a public statement, Ervin has enjoyed a most distinguished career in real estate management, investment banking, and mergers-acquisitions with numerous Fortune 500 companies, including the First Boston Corp., Fisher Brothers and Rockefeller Center Inc. In November 2003, Ervin became president and CEO of MicroBio-Medical Systems Inc.

To summarize recent developments, NanoSignal was pleased to recently announce a definitive agreement with Dr. Jeffery Taft, a veteran of the early days of the company when it was known as MicroSignal and based in Pennsylvania, to join NanoSignal Corp. as a technical and scientific consultant. With Taft`s addition to the team, NanoSignal Corp. is ready to pursue new applications of its technology -- most notably early detection of stroke. Cerebral blood flow and coronary artery blood flow are potential areas that show great promise using NanoSignal`s proprietary technology.

NanoSignal Corp. recently announced that it had entered into a consulting agreement with Al Noshirvani to develop sales and marketing of SLICES(TM). Noshirvani comes to NanoSignal with a wealth of sales and marketing experience, having been a sales professional in the medical equipment and health industries for more than 10 years. Noshirvani will help NanoSignal establish a national distribution network for SLICES(TM) and will implement a best business practices marketing program.

Incidentally, Noshirvani has scheduled a SLICES(TM) sales and marketing seminar for March 2004 in Las Vegas and further details will be announced when available.

NanoSignal announced recently that Felicia Browell has been hired to design a professional user manual for SLICES(TM). Browell will consult with Taft, Chris Puleo and Sherry Yavelak in accomplishing this project, and she will assist NanoSignal in creating comprehensive documentation that should make SLICES(TM) become recognized as the No. 1 leader in user-friendly software products for the MRI industry.

Ervin stated, "The company is actively in negotiations with multiple investment banking firms to meet its anticipated funding needs for national and international sales and marketing for the 2004-2005 period. Further details on this subject will be announced when warranted, and I would suggest that shareholders remain supportive and patient as the company transitions to what the management team believes will be bigger and better days ahead for NanoSignal. We appreciate the loyalty expressed by so many of the company`s shareholders in the past year."

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management`s strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.

Additional information regarding SLICES(TM) and NanoSignal Corp. is available at www.nanosignalcorp.com.

SOURCE: NanoSignal Corp.